Z-2834-2026 Class II Ongoing

Recalled by Beckman Coulter Biomedical GmbH — Munchen

FDA device recall Z-2834-2026 was initiated by Beckman Coulter Biomedical GmbH on Apr 29, 2026 and is designated Class II. Reason for recall: Due to software issues where does not handle combo assay results. The software may replace the final combo test result with one of the sub-results resulting in incorrect reporting of test outcomes. The recall status is ongoing. Affected quantity: 20 systems.

Recall details

Product Type
Devices
Report Date
Aug 12, 2026
Initiation Date
Apr 29, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20 systems

Product description

REMISOL Advance with Software Version 2.5 UDI-DI code: 15099590802073 The Normand Info REMISOL Advance Data Manager collects and manages data and workflow for 128 connections

Reason for recall

Due to software issues where does not handle combo assay results. The software may replace the final combo test result with one of the sub-results resulting in incorrect reporting of test outcomes.

Distribution pattern

U.S.: FL, GA, IL, MI, and PA O.U.S.: Belgium, France, Hungary, Poland, Taiwan (Province of China), Tunisia, United Arab Emirates, and United Kingdom of Great Britain and Northern Ireland.

Code information

Software Version 2.5 UDI-DI code: 15099590802073

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2834-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2834-2026. Report a data issue: hello@regdatalab.com.